Vertex Pharma (VRTX) Tops Q2 EPS by 83c
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $528.90 -3.15%
EPS Growth %: 0.0%
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
CULP, KFY, NNOX, More
EPS Growth %: 0.0%
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $3.11, $0.83 better than the analyst estimate of $2.28. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.72 billion.
GUIDANCE:
Vertex Pharma sees FY2021 revenue of $7.2-7.4 billion, versus the consensus of $6.99 billion.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Morgan Stanley Downgrades Vend Marketplaces (VEND:NO) to Equalweight
- JPMorgan Upgrades Lithium Americas Corp. (LAC:CN) (LAC) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
